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Abstract : Anaplastic thyroid cancer （ATC） has a poor prognosis because of imme-
diate metastasis.  Several studies in humans and animals have suggested that the 
ingestion of green tea or its active ingredient （–）-epigallocatechin-3-gallate （EGCG） 
may decrease the risk of cancer.  Using a recently developed real-time cell analysis 
（RTCA） system, we have shown previously that EGCG inhibits cell migration and 
the invasion of oral cavity cancers by suppressing matrix metalloproteinases.  In the 
present study we used RTCA to investigate the effects of EGCG on cell adhesion 
to bronectin-coated plates using three cancer cell lines : one ATC cell line （TCO-
1） and two poorly differentiated oral squamous cell carcinomas （OSCCs） cell lines 
（SAS and HO-1-u-1 ; originating from the tongue and oor of the mouth, respec-
tively）.  EGCG （50 µM） inhibited the adhesion of all three cell lines.  In addition 
to its effects on cell adhesion, 50 µM EGCG inhibited the cell proliferation of 
TCO-1 cells.  Furthermore, EGCG decreased αV integrin （ITGAV） mRNA levels 
in all three cell lines, suggesting that EGCG inhibits the cell adhesion and prolif-
eration of OSCC and ATC cells via suppression of integrin expression.  Therefore, 
EGCG represents a useful dietary constituent or a lead compound for counteract-
ing metastasis of oral cavity cancers and thyroid cancers.
Key words : anaplastic thyroid cancer, oral squamous cell carcinoma, adhesion,  
（–）-epigallocatechin-3-gallate （EGCG）, real-time cell analyzer
Introduction
　Green tea is consumed worldwide.  Because it contains catechins, green tea may have thera-
peutic potential in areas such as preventing cancer 1）, pollinosis 2）, and osteoporosis 3）.  There are 
four main catechins in green tea : （–）-epigallocatechin-3-gallate （EGCG）, （–）-epigallocatechin, 
（–）-epicatechin-3-gallate, and （–）-epicatechin 4）.  EGCG, the primary catechin in green tea, 
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exhibits strong activity in various assays, including antitumor, anti-oxidation, and anti-angiogenesis 
assays 5，6）.
　The xCELLigence real-time cell analysis （RTCA） system （SCRUM Inc., Tokyo, Japan） 
was developed for analysis of cell migration, invasion, and adhesion in vitro 7，8）.  This system 
uses impedance detection to create a cell index that is used for continuous monitoring of cell 
viability, migration, and invasion 7，8）.  In a previous study using RTCA we showed that EGCG 
inhibited cell migration and invasion in oral squamous cell carcinomas （OSCCs）9）.  Moreover, 
we have demonstrated that anaplastic thyroid cancer （ATC） cells （TCO-1） have high migratory 
and invasive activity in association with high periostin expression 10）.  In particular, TCO-1 cells 
exhibit very high periostin expression compared with other cell lines tested 10）.
　ATC is a rare and highly malignant form of thyroid cancer with a high mortality rate 11）. 
Treatment of ATC is very difcult and consequently the survival rate is very low for associated 
head and neck cancers.  At present, new therapeutic agents for ATC are in great demand.
　Periostin, the expression of which is elevated in TCO-1 cells, was originally identied as an 
811-amino acid protein secreted by osteoblasts 12）.  Periostin has frequently been observed as a 
major constituent of the extracellular milieu of desmoplastic malignant tumors 13）.  Periostin func-
tions as a ligand for αVβ3 and αVβ5 integrins to support the adhesion and migration of ovarian 
epithelial cells 12）.  However, few studies have examined the relationship between EGCG and 
periostin.
　Integrins permit dynamic bidirectional transmembrane signaling that is essential in cell adhe-
sion, migration, differentiation, and survival.  Human integrins have 18 α- and 8 β-subunits that 
combine to give 24 different αβ heterodimers 14）.  Iwamoto et al reported that talin binding 
conformationally activates transmembrane integrin adhesion receptors to increase their afnity for 
extracellular ligands and promotes integrin clustering for high-afnity adhesion to the extracel-
lular matrix14）.  Several studies have reported that EGCG inhibits the invasion and migration 
of cancer cells by suppressing the activation and expression of integrins 9，15，16）.  It is thought that 
EGCG plays an important role in suppressing cancer metastasis by inhibiting integrins.
　Previously, we reported on the inhibition of the migration and invasion of OSCCs using the 
RTCA system 9）.  Moreover, we reported that TCO-1 cells exhibit a strong migratory activity 
compared with OSCCs.  On the basis of these observations, we surmised that TCO-1 cells 
possess strong adhesive activity.  In the present study, we used RTCA to investigate EGCG 
inhibition of the adhesion of an ATC cell line, as well as that of cell lines from cancers of the 
tongue and the oor of the mouth, and also the associated expression of periostin and integrin 
mRNA.
Materials and methods
Cell lines and reagents
　All three cell lines used in the present study were provided by the Health Science Research 
Resources Bank （Osaka, Japan）.  TCO-1 （JCRB0239） cells were established from a human non-
differentiated thyroid cancer 17）, the SAS （JCRB0260） cell line was established from poorly 
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differentiated OSCC of the tongue 18）, and the HO-1-u-1 cell line （JCRB0828） was established 
from a poorly differentiated OSCC of the oor of the mouth 19）.  EGCG （MW458.37） was pur-
chased from Wako Pure Chemical Industries （Osaka, Japan）.
Cell culture
　All cell lines were cultured at 37°C in humidied atmosphere of 5％ CO2 and 95％ air in 
medium containing 10％ fetal bovine serum （FBS）, 100 U / ml penicillin, and 100 µg / ml strep-
tomycin.  TCO-1 cells were cultured in Dulbecco’s modied Eagle’s medium （DMEM）, whereas 
SAS and HO-1-u-1 cells were cultured in 45％ DMEM–45％ Ham’s F12 medium （DMEM / F12）. 
The medium was changed every 3 days 10，17-19）.
Hematoxylin–eosin staining
　After 6 h culture in the presence or absence of EGCG, TCO-1 cells were stained with hema-
toxylin–eosin （HE）.
Real-time cell analysis
　Previous studies have reported on the migration and invasion of OSCC cells as determined 
by RTCA 7，9，10）.  In the present study, adhesion was assessed on an RTCA system E-Plate 16 
coated with bronectin （20 mg / ml）.  TCO-1 cells （1.5×104）, SAS or HO-1-u-1 cells （1.0×105） 
were seeded onto an individual E-Plate 16s in 100 µL medium specic for each cell line without 
FBS.  The nal EGCG concentration in the TCO-1 medium was 10, 30, 50, 100, or 200 µM, 
whereas the final EGCG concentration in the SAS and HO-1-u-1 medium was 50, 100, or 
200 µM.  Changes in impedance resulting from cells that had migrated to the bottom side of the 
membranes were recorded every 15 min and were monitored for a total of 24 h.
　A unitless parameter, termed the cell index （CI）, was used to measure the relative change 
in electrical impedance as a marker of cell status.  The CI is a relative and dimensionless value 
because it represents the impedance change divided by a background value.
RNA isolation and quantitative real-time reverse transcription–polymerase chain reaction
　Head and neck cancer cells were seeded in six-well plates and grown for 1 week at 37°C. 
Total RNA was extracted using NucleoSpin RNA II （MACHEREY-NAGEL, Duren, Germany） 
after treatment with EGCG for 6 h.  Total RNA was reverse transcribed using the PrimeScript 
RT Master Mix （TaKaRa Bio, Shiga, Japan）.  The resulting cDNAs were amplied using primers 
designed with ProbeFinder software （Roche Applied Science, Mannheim, Germany） for periostin, 
α1 integrin （ITGA1）, ITGAV, and ITGB1.  Table 1 lists the primers used, the Roche Universal 
Probe Library probe numbers, and the gene accession numbers.  Amplication was performed 
with a LightCycler （Roche） using the LightCycler TaqMan Master mix （Roche）.  The PCR 
reaction parameters were as follows : 95°C for 10 min, followed by 45 cycles （except for 18s 
rRNA amplication＝25 cycles） of 10 s at 95°C, 30 s at 60°C, and 1 s at 72°C.  Fluorescence 
data were analyzed using LightCycler software （Roche）.  mRNA levels of the genes of inter-
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est were normalized against those of 18s rRNA used as an internal standard to yield relative 
expression ratios 7）.
Statistical analysis
　The normal distribution of baseline variables for all data was evaluated using the Bonferroni 
test following one-way analysis of variance （ANOVA）.  All data are expressed as the mean ±
SEM. P＜0.05 was considered signicant.
Results
　Fig. 1 shows HE-stained TCO-1 cells after 6 h culture in the absence （control） or presence of 
200 µM EGCG.  No obvious morphological changes （rounding and swelling） were observed after 
culturing cells in the presence of EGCG.  There was no clear evidence of apoptosis or necrosis 
after culture in the presence of 200 µM EGCG.  Similarly, EGCG did not induce apoptosis or 
necrosis in SAS and HO-1-u-1 cells （data not shown）.
　RTCA results of up to 6 h reflect changes in adhesion, whereas results after the 6-h time 
point reect changes in cellular proliferation.  Fig. 2 shows the effects of EGCG on cell adhe-
sion （0–6 h） and proliferation （6–24 h） on the bronectin-coated E-Plate 16s.  EGCG inhibited 
TCO-1 adhesion in a concentration-dependent manner （Fig. 2A）.  After incubation with EGCG 
for 5 h, the CI for control, 30, 50, and 200 µM EGCG-treated TCO-1 cells was 5.80 ± 0.40, 3.33
± 0.34, 0.68 ± 0.08, and 0.22 ± 0.02, respectively, with signicant reductions in the CI in the pres-
ence of EGCG at all concentrations tested （P＜0.01 vs control for all）.  EGCG （50 µM） treat-
ment resulted in a 97.8％ inhibition of cell proliferation for up to 24 h （Fig. 2A）.  The adhesion 
of SAS cells was signicantly decreased by 96.6％ after 5 h exposure to 200 µM EGCG （P＜
0.01 vs control and 50 µM EGCG）, by 43.9％ after 5 h exposure to 100 µM EGCG （P＜0.01 
vs control and 50 µM EGCG）, and by 8.92％ after 5 h exposure to 50 µM EGCG （P＞0.05 vs 
Table 1.  Nucleotide sequences of primers used for polymerase chain reaction
Gene Sequence Accession number Probe number
Periostin
Sense primer 5’-caccaaggtcaccaaattcat-3’
NM_001135934.1 #9Antisense primer 5’-ttcctcacgggtgtgtctc-3’
ITGA1
Sense primer 5’-aattggctctagtcaccattgtt-3’
NM_181501.1 #14Antisense primer 5’-caaatgaagctgctgactggt-3’
ITGAV
Sense primer 5’-gccgtggatttcttcgtg-3’
NM_002210.3 #64Antisense primer 5’-gaggacctgccctccttc-3’
ITGB1
Sense primer 5’-cgatgccatcatgcaagt-3’
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Fig. 1.   Hematoxylin–eosin （HE） staining. TCO-1 cells were fixed in 10％ formaldehyde for 1 h 
and were evaluated for morphological changes after 6 h culture in the presence of 200 µM 
（–）-epigallocatechin-3-gallate （EGCG） under an optical microscope after HE staining.
Fig. 2.   Adhesion of （A） TCO-1, （B） SAS, and （C） 
HO-1-u-1 cells to a fibronectin-coated substrate 
was analyzed using real-time cell analysis 
（RTCA）. Cells were seeded into wells of an 
E-Plate 16 （1.5×104 TCO-1 cells / well ; 1.0
×105 SAS and HO-1-u-1 cells / well） and 
allowed to adhere in the absence （Control） 
or presence of 10, 30, 50, 100, or 200 µM （–）
-epigallocatechin-3-gallate （EGCG）. Data are 
the mean ± SEM cell index （CI） of n wells 
（n＝16 ［control］, 9 ［10 µM EGCG］, 10 
［30 and 50 µM EGCG］, 7 ［100 µM］, and 8 
［200 µM］ in A ; n＝8 ［control, 50, 100, and 
200 µM EGCG］ in B ; n＝5 ［control］, 7 ［50 
and 100 µM］, and 4 ［200 µM］ in C）. ＊P＜
0.05, ＊＊P＜0.01 compared with control ; †
P＜0.05, ††P＜0.01 compared with 10 µM 
EGCG ; §P＜0.05, §§P＜0.01 compared with 
50 µM EGCG.
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control ; Fig. 2B）.  The adhesion of HO-1-u-1 cells was decreased by 95.2％ after 5 h exposure 
to 200 µM EGCG （P＜0.01 vs control and 50 µM EGCG）, by 79.8％ after 5 h exposure to 
100 µM EGCG （P＜0.01 vs control and 50 µM EGCG）, and by 34.0％ after 5 h exposure to 
50 µM EGCG （P＜0.05 vs control ; Fig. 2C）.  There were no clear effects of EGCG on the 
proliferation of HO-1-u-1 and SAS cells.
　Fig. 3 shows periostin mRNA expression in head and neck cancer cells after 6 h exposure 
to EGCG.  In these experiments, control expression was set at 100％.  EGCG had no signi-
cant effect on periostin mRNA levels in TCO-1 cells （Fig. 3A）, but there was a tendency for 
decreases in periostin mRNA levels in SAS and HO-1-u-1 cells after exposure to EGCG com-
pared with control （Fig. 3B, C）.
　Fig. 4–6 show ITGA1, ITGAV, and ITGB1 mRNA expression in head and neck cancer cells 
after 6 h treatment with EGCG.  In these experiments, control expression was set at 100％. 
EGCG had no signicant effect on ITGA1 mRNA levels in TCO-1 （Fig. 4A）, SAS （Fig. 4B）, 
or HO-1-u-1 （Fig. 4C） cells.  Treatment of TCO-1 cells with 30 and 50 µM EGCG resulted in 
a 61.3％ and 9.8％ decrease in ITGAV mRNA levels, respectively, compared with control （P＜
0.05 vs 30 µM EGCG and P＜0.01 vs 50 µM EGCG ; Fig. 5A）.  Treatment of SAS cells with 
50, 100, and 200 µM EGCG resulted in a 59.7％, 52.5％, and 59.8％ decrease in ITGAV mRNA 
levels, respectively, compared with control （P＜0.01 for all ; Fig. 5B）.  Similarly, EGCG （50, 100, 
and 200 µM） treatment of HO-1-u-1 cells decreased ITGAV mRNA expression by 56.8％, 41.0％, 
Fig. 3.   Periostin mRNA expression in the absence or presence of （–）-epigallocatechin-
3-gallate （EGCG） was determined using quantitative real-time polymerase 
chain reaction in （A） TCO-1, （B） SAS, and （C） HO-1-u-1 cells and is 
shown relative to that in the absence of EGCG. Data are the mean ± SEM 
（n＝12 ［0 µM ; Control］, 12 ［10 µM］, 12 ［30 µM］, and 12 ［50 µM］ in A ; n
＝9 ［0 µM］, 5 ［50 and 100 µM］, and 6 ［200 µM］ in B ; n＝10 ［0 µM］, 6 
［50 and 100 µM］, and 5 ［200 µM］ in C）.
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Fig. 4.   ITGA1 mRNA expression in the absence or presence of （–）-epigallocatechin-
3-gallate （EGCG） was determined using quantitative real-time polymerase 
chain reaction in （A） TCO-1, （B） SAS, and （C） HO-1-u-1 cells and is 
shown relative to that in the absence of EGCG. Data are the mean ± SEM 
（n＝6 ［0 µM］ and 6 ［10, 30, and 50 µM］ in A ; n＝9 ［0 µM］ and 6 ［50, 
100, and 200 µM］ in B ; n＝9 ［0 µM］ and 6 ［50, 100, and 200 µM］ in C）.
Fig. 5.   ITGAV mRNA expression in the absence or presence of （–）-epigallocatechin-
3-gallate （EGCG） was determined using quantitative real-time polymerase 
chain reaction in （A） TCO-1, （B） SAS, and （C） HO-1-u-1 cells and is 
shown relative to that in the absence of EGCG. Data are the mean ± SEM 
（n＝6 ［0 µM］ and 6 ［10, 30, and 50 µM］ in A ; n＝18 ［0 µM］, 15 ［50 
and 100 µM］, and 14 ［200 µM］ in B ; n＝6 ［0 µM］ and 9 ［50, 100, and 
200 µM］ in C）. ＊P＜0.05, ＊＊P＜0.01 compared with 0 µM.
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and 44.4％, respectively, compared with control （P＜0.05 vs 50 µM EGCG and P＜0.01 vs 
100 µM and 200 µM EGCG ; Fig. 5C）.  EGCG had no signicant effect on ITGB1 mRNA levels 
in TCO-1 （Fig. 6A） or SAS （Fig. 6B） cells.  However, treatment of HO-1-u-1 cells with 50, 100, 
and 200 µM EGCG resulted in a 157.8％, 200.5％, and 212.7％ increase in ITGB1 mRNA levels, 
respectively, compared with control （P＜0.05 for all ; Fig. 6C）.
Discussion
　In the present study, RTCA was used to demonstrate that EGCG inhibited the adhesion 
of ATC and poorly differentiated OSCC cell lines in real time and that these responses were 
associated with changes in the expression of αV integrin but not periostin.  The use of RTCA 
facilitated the identication of the effects of EGCG on three types of head and neck cancer 
cells, demonstrating signicant inhibition of cell adhesion by EGCG.
　Prominent extracellular matrix （ECM） proteins include fibronectin, laminin, and collagens. 
These proteins are deeply involved in tumor growth, invasion, and metastasis because of adhesive 
interactions between tumor cells and the ECM 20）.  Using bronectin-coated E-Plate 16s in the 
present study revealed that EGCG directly inhibited cancer cell interactions with fibronectin. 
Moreover, Suzuki et al reported that EGCG binds β1 integrin 21）.  Therefore, EGCG strongly 
and directly inhibits the binding of cells to the ECM.  Moreover, RTCA indicated that EGCG 
inhibited the adhesion of all cells in a concentration-dependent manner.  In particular, EGCG 
inhibited TCO-1 cell adhesion and proliferation.  The ndings of the present study show that at 
Fig. 6.   ITGB1 mRNA expression in the absence or presence of （–）-epigallocatechin-
3-gallate （EGCG） was determined using quantitative real-time polymerase 
chain reaction in （A） TCO-1, （B） SAS, and （C） HO-1-u-1 cells and is 
shown relative to that in the absence of EGCG. Data are the mean ± SEM 
（n＝6 ［0, 10, 30, and 50 µM］ in A ; n＝12 ［0 µM］, 6 ［50 and 100 µM］, and 
5 ［200 µM］ in B ; n＝9 ［0 µM］ and 6 ［50, 100, and 200 µM］ in C）. ＊P＜
0.05 compared with 0 µM.
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100 and 200 µM, EGCG prevents the adhesion of TCO-1 cells to the surface of the plate.  It is 
important to note that the CI is not altered by the presence of cells on the surface of the plate 
in the absence of adhesion 22，23）.  Lim and Cha reported that EGCG （50–200 µM） inhibited 
cell proliferation and induced apoptosis in an ATC cell line （ARO cells） via suppression of the 
epidermal growth factor receptor （EGFR）/ extracellular signal-regulated kinase （ERK） pathway 
and cyclin B1 / CDK1 complex 24）.  However, in the present study, 200 µM EGCG did not induce 
apoptosis in TCO-1 cells.
　Clinical studies of periostin expression in human cancers have found that increased expres-
sion of periostin is correlated with tumor metastasis 25，26）.  Gillan et al reported that periostin 
promotes adhesion and potentiates cancer cell motility through binding to αVβ3 and αVβ5 
integrins 12）.  However, in the present study, EGCG did not decrease the expression of periostin 
mRNA in TCO-1 cells, and only 50 µM EGCG reduced αV integrin mRNA expression in TCO-
1 cells by 90％.  Yan and Shao reported that cellular adhesion of 293T cells required signaling 
through αVβ5 integrin 27）.  Therefore, EGCG suppresses adhesion of TCO-1 cells regardless of 
the overexpression of periostin observed in our previous study 10）.
　ATC is a very aggressive solid tumor with a poor prognosis.  Surgery, radiotherapy, and 
chemotherapy do not improve the mean survival time, which is in the range of 2–6 months 28）. 
EGCG may become a potential treatment for ATC that cannot be otherwise treated effectively. 
Previous studies have demonstrated that one consumption of green tea extract （1.5–4.5 g or 1–3 
cups） by healthy individuals results in plasma concentrations of EGCG of only 4 µM 29）.  The 
ingestion of benifuuki tea, which contains O-methylated catechin, results in higher EGCG blood 
concentrations and may have a more benecial effect than other green teas 30）.  It is necessary 
to devise an effective means to administer EGCG, such as O-methylated EGCG, because it will 
be difcult to immediately use EGCG in a clinical setting.
　In conclusion, using RTCA technology we clearly showed that EGCG inhibited the adhesion 
and proliferation responses of an ATC cell line in real time.  The ndings of the present study 
suggest that EGCG may be a lead compound for reducing the metastases of ATC by inhibiting 
integrins.
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